Mitochondria dysfunction was involved in copper-induced toxicity in MES23.5 cells

被引:15
|
作者
Shi L.-M. [1 ]
Jiang H. [1 ]
Wang J. [1 ]
Ma Z.-G. [1 ]
Xie J.-X. [1 ]
机构
[1] State Key Disciplines: Physiology (In Incubation), Department of Physiology, Qingdao University
基金
中国国家自然科学基金;
关键词
Copper; Dopamine; Mitochondria;
D O I
10.1007/s12264-008-0079-5
中图分类号
学科分类号
摘要
Objective: To investigate the toxicity of copper on MES23.5 dopaminergic cells and the probable mechanisms involved in this process. Methods: MES23.5 dopaminergic cells were selected as our experimental model. [3-(4, 5-dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide] (MTT) assay was used to detect the influence of copper on the cell viability. The semi-quantitative reverse transcription polymerase chain reaction (RT-PCR), Western blotting and the high performance liquid chromatography-electrochemical detection (HPLC-ECD) have been used to detect the tyrosine hydroxlase (TH) mRNA and protein expression and the dopamine content in MES23.5 cells. The flow cytometry have been used to detect the changes of mitochondrial transmembrane potential. Results: 100 and 200 μmol/L copper had no effect on the MES23.5 cell viability, whereas 400 and 800 μmol/L of copper could decrease the cell viability (P < 0.01). Treating cells with 200 μmol/L copper for 24 h decreased the TH mRNA expression, the TH expression and the dopamine content compared with the control (P < 0.01, P < 0.01, P < 0.05, respectively). Besides, the mitochondrial transmembrane potential also decreased with the treatment of 200 μmol/L copper for 24 h (P < 0.01). Conclusion: Copper could exert the toxic effects on MES23.5 dopaminergic cells and decrease the cell function. The dysfunction of mitochondria may be the mechanism of this toxicity effect. © 2008 Shanghai Institutes for Biological Sciences, CAS and Springer-Verlag GmbH.
引用
收藏
页码:79 / 83
页数:4
相关论文
共 50 条
  • [1] Potassium Channels Are Involved in Zinc-Induced Apoptosis in MES23.5 Cells
    Shi, Limin
    Song, Ning
    Jiang, Hong
    Wang, Jun
    Ma, Zegang
    Xie, Junxia
    JOURNAL OF NEUROSCIENCE RESEARCH, 2009, 87 (02) : 514 - 521
  • [2] POTASSIUM CHANNELS WERE INVOLVED IN ZINC-INDUCED APOPTOSIS IN MES23.5 CELLS
    Shi, Li Min
    Jiang, Hong
    Wang, Jun
    Ma, Ze Gang
    Xie, Jun Xia
    CELL BIOLOGY INTERNATIONAL, 2008, 32 (03) : S10 - S10
  • [3] FERROPORTIN1 BUT NOT HEPHAESTIN WAS INVOLVED IN THE 6-HYDROXYDOPAMINE INDUCED IRON ACCUMULATION IN MES23.5 CELLS
    Song, Ning
    Wang, Jun
    Jiang, Hong
    Xie, Junxia
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 512 - 512
  • [4] Ghrelin protects MES23.5 cells against rotenone via inhibiting mitochondrial dysfunction and apoptosis
    Yu, Jianhan
    Xu, Huamin
    Shen, Xiaoli
    Jiang, Hong
    NEUROPEPTIDES, 2016, 56 : 69 - 74
  • [5] Myricetin reduces cytotoxicity by suppressing hepcidin expression in MES23.5 cells
    Han Deng
    Shang Liu
    Dong Pan
    Yi Jia
    Ze-Gang Ma
    Neural Regeneration Research, 2021, 16 (06) : 1105 - 1110
  • [6] Myricetin reduces cytotoxicity by suppressing hepcidin expression in MES23.5 cells
    Deng, Han
    Liu, Shang
    Pan, Dong
    Jia, Yi
    Ma, Ze-Gang
    NEURAL REGENERATION RESEARCH, 2021, 16 (06) : 1105 - 1110
  • [7] Nesfatin-1 antagonized rotenone-induced neurotoxicity in MES23.5 dopaminergic cells
    Tan, Zhen
    Xu, Huamin
    Shen, Xiaoli
    Jiang, Hong
    PEPTIDES, 2015, 69 : 109 - 114
  • [8] Over-expressed human divalent metal transporter 1 is involved in iron accumulation in MES23.5 cells
    Xu, Hua-Min
    Jiang, Hong
    Wang, Jun
    Luo, Bing
    Xie, Jun-Xia
    NEUROCHEMISTRY INTERNATIONAL, 2008, 52 (06) : 1044 - 1051
  • [9] Oxidative stress induced intranuclear accumulation of α-synuclein in MES23.5 dopaminergic neurons
    Xu, S
    Zhou, M
    Zhang, A
    Chan, P
    JOURNAL OF NEUROCHEMISTRY, 2003, 87 : 101 - 101
  • [10] Ferroportin1 but not hephaestin was involved in the 6-hydroxydopamine induced iron accumulation in primary ventral mesencephalic neurons and MES23.5 cells
    Song, N.
    Wang, J.
    Jiang, H.
    Xie, J.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S185 - S185